ArticleBMC infectious diseases2026
Clinical and biological risk factors influencing infant HIV status: a case study of Kisenyi Health Center IV, Kampala, Uganda.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTransmission of HIV from mother to child (MTCT) contributes to 18% of new HIV infections in Uganda. This study aimed at investigating how clinical and biological risk factors were associated with the transmission of HIV from mothers to children in Uganda.
methodsThis study utilized secondary data extracted from patient charts of 200 mothers living with HIV and their children who received services at Kisenyi Health Centre IV between 2017 and 2022. To model the relationship between the independent factors and the child’s HIV status, the Probit regression model was used.
resultsAmong the children, 22.5% were living with HIV. The type of antiretroviral (ARV) regimen administered to the mother significantly influenced the child’s HIV status. Specifically, the AZT/3TC/NVP regimen (Zidovudine, Lamivudine, Nevirapine) was associated with a statistically significant increase in the odds of HIV positivity in children (OR = 5.12; p = 0.016). Children whose mothers received the ABC/3TC/LPV regimen had 2.49 times higher odds of living with HIV compared to those on regimen TDF/3TC/EFV (p = 0.017). Additionally, maternal HIV viral load was a significant biological determinant of the child’s HIV status. A viral load above 1000 copies/mL was associated with a fivefold increase in the odds of the child living with HIV (OR = 5.06; p < 0.001).
conclusionsThese findings highlight the importance of clinical decision-making, particularly the choice of ARV regimen, and the monitoring of maternal HIV viral load during pregnancy to optimize the likelihood of delivering an HIV-negative child. The study further recommends that future research and targeted interventions build on these results to improve HIV treatment outcomes in pediatric populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.